Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity

Clinical Colorectal Cancer(2022)10.1016/j.clcc.2022.01.006Source: DataRank Database

Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity is a research paper published in Clinical Colorectal Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.49)OA: greenTopics (24)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Neil H. Segal ORCID,Andrea Cercek ORCID,Rona Yaeger ORCID,Zsofia K. Stadler ORCID,Nancy E. Kemeny ORCID

Live enrichment

PubMed:35125319 PMC:PMC9149089 OpenAlex:https://openalex.org/W4206390864

Conquer Cancer Foundation

Grant: 2021YIA-8302348290

National Institutes of Health

Grant: P30 CA 008748

National Institutes of Health

Grant: T32‐CA009512

NCI NIH HHS

Grant: T32 CA009512

FWCI

0.49

Citation Percentile

0.6%

Citation Trend

2022

2025

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9149089

publisherhttps://api.elsevier.com/content/article/PII:S1533002822000068?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1533002822000068?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.clcc.2022.01.006

Fields of Study

Drug-Induced Adverse ReactionsPharmacovigilance and Adverse Drug ReactionsChemotherapy-related skin toxicityAntineoplastic AgentsDesensitization, ImmunologicDrug HypersensitivityHumansOxaliplatinRetrospective Studies

MeSH Terms

OxaliplatinAntineoplastic AgentsDesensitization, ImmunologicDrug HypersensitivityHumansRetrospective Studies

Keywords

MedicineOxaliplatinColorectal cancerIntensive care medicineInternal medicineCancerDesensitizationHypersensitivityGraded Infusion

Sustainable Development Goals

SDG 0: Good health and well-being